A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

Amy Schumer shared she quit Wegovy due to side effects like nausea but was "having a really good experience" with Mounjaro, ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...

The robust pipeline is a result of Lilly's strong commitment to research. We believe cardiometabolic drugs Mounjaro, Zepbound, and Jardiance as well as immunology drug Taltz, cancer drug Verzenio ...

Lilly claims Premier Weight Loss is selling altered versions of Lilly's weight loss drugs Zepbound and Mounjaro. In the lawsuit, Lilly alleges Premier Weight Loss is falsely marketing Lilly's ...

Since 2023, Lilly has taken action against dozens of pharmacies, weight-loss centers and health spas over the drugs Mounjaro and Zepbound accounted for more than one-third of Lilly’s record $45 ...

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials. For some patients, injectables ...

Tirzepatide is the ingredient behind Lilly's major obesity and diabetes franchise Zepbound and Mounjaro and works as a long-acting GIP (glucose-dependent insulinotropic polypeptide) receptor and ...

Mounjaro (tirzepatide ... The 40-week study — sponsored by Eli Lilly, the manufacturer of both drugs — aimed to address this question. Researchers compared the safety and efficacy of gradually ...